AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan · Delayed Price · Currency is TWD 53.90
-1.20 (-2.18%)
Aug 19, 2026, 12:42 PM CST
AnnJi Pharmaceutical Revenue
AnnJi Pharmaceutical had revenue of 419.00K TWD in the half year ending December 31, 2025, a decrease of -99.59%. This brings the company's revenue in the last twelve months to 959.00K, down -95.98% year-over-year. In the year 2025, AnnJi Pharmaceutical had annual revenue of 7.55M, down -92.17%.
Revenue (ttm)
959.00K
Revenue Growth
-95.98%
P/S Ratio
5,404.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.18B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.55M | -88.90M | -92.17% |
| Dec 31, 2024 | 96.45M | -47.08M | -32.80% |
| Dec 31, 2023 | 143.53M | 141.90M | 8,727.18% |
| Dec 31, 2022 | 1.63M | 191.00K | 13.31% |
| Dec 31, 2021 | 1.44M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.45B |
| Medigen Biotechnology | 1.34B |
| Savior Lifetec | 1.17B |
| Mycenax Biotech | 815.34M |
| TaiGen Biopharmaceuticals Holdings | 258.93M |
| Pharmosa Biopharm | 69.06M |
| UnicoCell Biomed | 22.46M |
| Acepodia | 185.00K |